首页|2016-2022年绵阳市耐药肺结核患者流行病学特征分析

2016-2022年绵阳市耐药肺结核患者流行病学特征分析

扫码查看
目的 分析绵阳市耐药肺结核的发病情况及流行特征,为耐药肺结核控制工作提供参考.方法 收集2016-2022年绵阳市登记管理的耐药肺结核患者数据,采用百分比、构成比进行流行病学描述分析,率的比较采用x2检验,以P<0.05为差异有统计学意义.结果 2016年绵阳市耐药肺结核患者登记率为0.92/10万,在2018年达到峰值1.43/10万,2022年耐药患者登记率为0.50/10万.性别分布上,2016、2022年男性分别占70.45%和70.83%,女性分别占29.55%和29.17%.年龄分布上,2016-2022年均以 15~59岁年龄段发病最多,分别占 84.09%、60.00%、71.01%、80.49%、63.33%、64.52%和62.50%.职业分布上,2016-2022年耐药患者始终以农民为主,分别占77.27%、60.00%、66.66%、75.61%、50.00%、58.07%和54.16%.耐药患者登记分类中,新患者比例最高,其次是复治患者.结论 绵阳市耐药肺结核患者登记率在2018年达到高峰,已连续4年呈下降趋势,需持续关注绵阳市耐药患者登记情况和治疗成功率,提高患者依从性,加强重点人群筛查,减少耐药结核病传播.
Epidemiological characteristics of drug-resistant pulmonary tuberculosis in Mianyang City from 2016 to 2022
Objective To analyze the epidemiological characteristics of drug-resistant pulmonary tuberculosis in Mianyang City,and to provide reference for prevention and control of drug-resistant pulmonary tuberculosis.Methods The data of patients with drug-resistant pulmonary tuberculosis registered in Mianyang City from 2016 to 2022 were collected,descriptive epidemiology method was used to analyze the percentages and constituent ratios,the rate was compared by Chi-square test,the difference was statistically significant with P<0.05.Results The registration rate of drug-resistant patients in Mianyang City was 0.92/105 in 2016 and reached its peak(1.43/105)in 2018,the registration rate of drug-resistant patients in 2022 was 0.50/105.In terms of gender distribution,men accounted for 70.45%and 70.83%respectively in 2016 and 2022,women accounted for 29.55%and 29.17%respectively in 2016 and 2022.From 2016 to 2022,the incidence was the highest in the 15-59 age group,accounting for 84.09%,60.00%,71.01%,80.49%,63.33%,64.52%and 62.50%,respectively.Farmers were the main drug-resistant patients,accounting for 77.27%,60.00%,66.66%,75.61%,50.00%,58.07%and 54.16%,respectively from 2016 to 2022.In the registration classification of drug-resistant patients,the proportion of newly diagnosed patients was the highest,followed by re-treatment patients.Conclusions The drug-resistant registration rate in Mianyang reached its peak in 2018 and showed a downward trend for four consecutive years.It is necessary to pay close attention to the drug-resistant registration and success rate of treatment,the compliance of patients should be improved,the screening of key populations should be strengthened and the spread of drug-resistant tuberculosis should be reduced.

drug-resistant pulmonary tuberculosisepidemiological characteristicsincidence

向金凤、杨小蓉

展开 >

绵阳市疾病预防控制中心,四川 绵阳 621000

耐药肺结核 流行病学特征 发病率

2024

寄生虫病与感染性疾病
中华预防医学会 四川省疾病预防控制中心

寄生虫病与感染性疾病

影响因子:0.335
ISSN:1672-2116
年,卷(期):2024.22(1)
  • 13